GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc. combined with Capstar Special Purpose Acquisition Corp (Nasdaq: CPSR), a blank-check company that completed its IPO in 2020 with a focus on the healthcare sector. Capstar Special Purpose Holdings LLC served as sponsor. The 8-K/A filed on July 20, 2021 represents an amendment to a current report submitted in connection with the announced business combination between CPSR and Gelesis, a biopharmaceutical company developing orally administered, superabsorbent hydrogel treatments targeting obesity and metabolic disease. The transaction placed Gelesis in the healthcare and medical technology space, and the company subsequently listed on the New York Stock Exchange under the ticker GELS following deal closure in early 2022. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on this and hundreds of other SPAC transactions.